The University of Chicago Header Logo

Connection

Rolf Barth to Abatacept

Back to Details
This is a "connection" page, showing publications Rolf Barth has written about Abatacept.
Rolf Barth
Connection Strength
0.879
Abatacept
  1. Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts. Clin Transplant. 2019 06; 33(6):e13531.
    View in: PubMed
    Score: 0.657
  2. Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation. 2014 Jan 27; 97(2):133-7.
    View in: PubMed
    Score: 0.115
  3. Transplantation: The promise of co-stimulatory blockade in transplantation. Nat Rev Nephrol. 2013 Apr; 9(4):189-90.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.